ISSN 1662-4009 (online)

ey0017.12-5 | Type 2 Diabetes | ESPEYB17

12.5. Liraglutide in children and adolescents with type 2 diabetes

WV Tamborlane , M Barrientos-Perez , U, et al. Fainberg

To read the full abstract: N Engl J Med. 2019;381(7):637–46. doi: 10.1056/NEJMoa1903822Short summary: Liraglutide is superior to placebo in improving glycaemic control in children and adolescents with T2DM.Comment: Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, also known as an incretin mimetic. It causes glucose-dependent sti...